Phase 1/2 Study of Zilovertamab and Ibrutinib in Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), or Marginal Zone Lymphoma (MZL)
| Autor: | Lee, Hun Ju, Choi, Michael Y., Siddiqi, Tanya, Rhodes, Joanna M., Wierda, William G., Isufi, Iris, Tuscano, Joseph M, Lamanna, Nicole, Subbiah, Suki, Koff, Jean L., Leslie, Lori, Goldenberg, Alec *, Chung, Gina G *, Breitmeyer, James B., Yazji, Salim, Wang, Michael, Jamieson, Catriona, Kipps, Thomas J. |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:566-568 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|